Patients with high-risk melanoma who had a course of pembrolizumab after their surgery had a longer time before their disease recurred than patients who got either […]
A new method to monitor epidemics like COVID-19 gives an accurate real-time estimate of the growth rate of an epidemic by carefully evaluating the relationship between […]
Performance-based financial penalties against outpatient dialysis centers under the End-Stage Renal Disease Quality Incentive Program (ESRD QIP) do not improve performance scores, according to a study […]
The cost of COVID-19 hospitalizations averaged nearly $22,000 for older Americans in 2020—and much more for those who became critically ill, a new government study finds.